296 related articles for article (PubMed ID: 38240572)
41. Insulin receptor signaling engages bladder urothelial defenses that limit urinary tract infection.
Schwartz L; Salamon K; Simoni A; Eichler T; Jackson AR; Murtha M; Becknell B; Kauffman A; Linn-Peirano S; Holdsworth N; Tyagi V; Tang H; Rust S; Cortado H; Zabbarova I; Kanai A; Spencer JD
Cell Rep; 2024 Apr; 43(4):114007. PubMed ID: 38517889
[TBL] [Abstract][Full Text] [Related]
42. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
43. Management of uncomplicated recurrent urinary tract infections.
Zare M; Vehreschild MJGT; Wagenlehner F
BJU Int; 2022 Jun; 129(6):668-678. PubMed ID: 34741796
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
[TBL] [Abstract][Full Text] [Related]
45. Probiotics for preventing urinary tract infection in people with neuropathic bladder.
Toh SL; Boswell-Ruys CL; Lee BSB; Simpson JM; Clezy KR
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010723. PubMed ID: 28884476
[TBL] [Abstract][Full Text] [Related]
46. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
47. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE
Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593
[TBL] [Abstract][Full Text] [Related]
48. UroPathogenic
Terlizzi ME; Gribaudo G; Maffei ME
Front Microbiol; 2017; 8():1566. PubMed ID: 28861072
[TBL] [Abstract][Full Text] [Related]
49. Variability in cell division among anatomical sites shapes Escherichia coli antibiotic survival in a urinary tract infection mouse model.
Amoura A; Pistien C; Chaligné C; Dion S; Magnan M; Bridier-Nahmias A; Baron A; Chau F; Bourgogne E; Le M; Denamur E; Ingersoll MA; Fantin B; Lefort A; El Meouche I
Cell Host Microbe; 2024 Jun; 32(6):900-912.e4. PubMed ID: 38759643
[TBL] [Abstract][Full Text] [Related]
50. N-Acetylcysteine Protects Bladder Epithelial Cells from Bacterial Invasion and Displays Antibiofilm Activity against Urinary Tract Bacterial Pathogens.
Manoharan A; Ognenovska S; Paino D; Whiteley G; Glasbey T; Kriel FH; Farrell J; Moore KH; Manos J; Das T
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438950
[No Abstract] [Full Text] [Related]
51. Murine Ribonuclease 6 Limits Bacterial Dissemination during Experimental Urinary Tract Infection.
Cortado H; Kercsmar M; Li B; Vasquez-Martinez G; Gupta S; Ching C; Ballash G; Cotzomi-Ortega I; Sanchez-Zamora YI; Boix E; Zepeda-Orozco D; Jackson AR; Spencer JD; Ruiz-Rosado JD; Becknell B
J Innate Immun; 2024; 16(1):283-294. PubMed ID: 38744252
[TBL] [Abstract][Full Text] [Related]
52. Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.
Bradley MS; Cabrera C; Clark SG; Sassani J; Venuti K; Ackenbom MF
Neurourol Urodyn; 2020 Nov; 39(8):2186-2191. PubMed ID: 32803912
[TBL] [Abstract][Full Text] [Related]
53. Reaching the End of the Line: Urinary Tract Infections.
Tamadonfar KO; Omattage NS; Spaulding CN; Hultgren SJ
Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172909
[TBL] [Abstract][Full Text] [Related]
54. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
55. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
[TBL] [Abstract][Full Text] [Related]
56. Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli.
Greene SE; Hibbing ME; Janetka J; Chen SL; Hultgren SJ
mBio; 2015 Jun; 6(4):e00820. PubMed ID: 26126855
[TBL] [Abstract][Full Text] [Related]
57. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
Totsika M; Kostakioti M; Hannan TJ; Upton M; Beatson SA; Janetka JW; Hultgren SJ; Schembri MA
J Infect Dis; 2013 Sep; 208(6):921-8. PubMed ID: 23737602
[TBL] [Abstract][Full Text] [Related]
58. Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection.
Chen YC; Lee WC; Chuang YC
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108218
[TBL] [Abstract][Full Text] [Related]
59. Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs.
Blango MG; Ott EM; Erman A; Veranic P; Mulvey MA
PLoS One; 2014; 9(3):e93327. PubMed ID: 24667805
[TBL] [Abstract][Full Text] [Related]
60. Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection.
De Nisco NJ; Neugent M; Mull J; Chen L; Kuprasertkul A; de Souza Santos M; Palmer KL; Zimmern P; Orth K
J Mol Biol; 2019 Oct; 431(21):4368-4379. PubMed ID: 31002774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
